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ABSTRACT 
Objective: The objective of the study was to develop and validate a new rapid and sensitive reverse phase ultra-performance liquid 
chromatographic (RP-UPLC) method for determination of cefdinir in bulk drug and dosage form.  
Methods: Separation was achieved with an Acquity SB C18 (100 × 2 mm) 1.8μm column with an isocratic mobile phase containing a mixture of 
orthophosphoric acid and acetonitrile (60:40 v/v) and pH adjusted to 2.8. The flow rate of the mobile phase was 0.3 ml/min with a column 
temperature of 30 °C and detection wavelength at 285 nm.  
Results: The method was validated with respect to linearity, accuracy, precision, detection limits, robustness and specificity. The precision of the 
results, stated as the relative standard deviation was below 1.5%. The calibration curve was linear over a concentration range from 25 to 150μg/ml 
with a correlation coefficient of 0.9993. The accuracy of the method demonstrated at three levels in the range of 50%, 100% and 150% of the 
specification limit. The recovery of cefdinir was found to be in the range of 98 to 102%, whereas the detection limits were found to be 0.17 and 
0.51µg/ml. Forced degradation study was carried out under acidic, alkaline, oxidative, photolytic and thermal conditions to prove the stability-
indicating ability of the developed UPLC method.  
Conclusion: The developed method was validated with respect to linearity, accuracy, precision limit of detection and quantification, robustness and 
specificity. The method was applied successfully for the determination of cefdinir in tablets.  
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Pharmaceutical analysis by definition deals with the analysis of 
drugs, pharmaceutical substances and raw materials. Drug analysis 
exposes identification, characterization and determination of the 
drugs in dosage forms and biological fluids etc. The international 
conference on harmonisation (ICH) guidelines attained a great deal in 
harmonizing the definitions of the impurities in new drug substances 
[1]. It is required to perform all the investigations on suitable 
reference standards of drug and impurities to acquire meaningful 
specifications. In order to meet the tasks to confirm the high degree of 
purity of drug substances and drug products, a system is proposed for 
profiling drug impurity. Lastly, analytical methods based on analytical 
instrumentation must be employed to quantitate drug substance and 
its impurities. Drug analysis is performed by various analytical 
methods like spectral methods, electroanalytical methods and 
chromatographic methods. HPLC has proven to be predominant 
technology used in laboratories worldwide during past 30 y [2, 3]. 
High-performance liquid chromatography (HPLC) is one mode of 
chromatography, one of the utmost used analytical techniques. As 
HPLC methods have been commonly used for routine quality control 
assessment of drugs, because of its sensitivity, repeatability and 
specificity. However, HPLC is a well-known technique used in 
controlling the quality and consistency of active pharmaceutical 
ingredients (API ʹs) and dosage forms. It is often a slow technique 
because of the complexity of some of the samples and it could still be 
enhanced. A novel category of separation technique, ultra-
performance liquid chromate-graphy (UPLC), has proven to be one of 
the most promising developments in the area of fast chromatographic 
separations with its unique characteristics of high chromatographic 
resolution, speed and sensitivity analysis [4]. UPLC provides the speed 
by using novel low micron particles that decreases chromatographic 
run times and also double peak capacity or resolution time [5]. UPLC 
uses 95 percent less solvent and significantly improves productivity in 
the laboratory. UPLC system reduces considerable time and cost per 
sample from the analytical process while improving the quality of 
results, the system allows chromatographers to work at higher 
efficiencies, flow rates and back pressures [6].  
Cefdinir, chemically is [6R-[6α, 7β (Z)]]-7-[[(2-amino4-thiozolyl) 
(hydroxyimino) acetyl] amino]-3ethenyl-8-oxo-5-thia-1-azabicyclo 
(4.2.2)-Oct-2-one-2-carboxylic acid [7]. The empirical formula of 
cefdinir is C14H13N5O5S2
MATERIALS AND METHODS 
 with a molecular weight of 395.42 [8]. 
Cefdinir is a semisynthetic cephalosporin antibiotic. The drug is an 
oral aminothiazolyl hydroxyimino cephalosporin. It has a broad 
spectrum of activity, excellent therapeutic action against susceptible 
gram-positive and gram-negative bacteria as having potent 
antimicrobial activity, excellent efficacy, convenient dosing and 
favorable tolerability compared with other antimicrobial agents. 
Cefdinir shows its bactericidal action by inhibiting cell wall synthesis 
[9]. It is found to be constant in presence of some, but not all β-
lactamase enzymes. As a result, many organisms resistant to 
penicillin’s and some cephalosporin are susceptible to Cefdinir [9]. 
Entire survey of the literature of cefdinir exposed several methods for 
determination in pharmaceutical formulations and biological matrices 
like spectro-photometry [10], polarographic technique [11], HPLC [12] 
and LC/MS/MS methods [13]. However, maximum of these analytical 
methods do not appear to have general utility especially at the industrial 
level where simple, cost-effective and specific methods are needed [14]. 
There are very limited works that have been done on this drug by HPLC 
but no method has been stated by UPLC technique. Thus, the objective of 
work was to develop and validate a stability indicating RP-UPLC method 
for the determination of cefdinir in bulk drug and dosage forms  
Instruments 
The chromatography analysis was performed using a Waters 
Acquity UPLC separation module (Waters Corporation, Milford, USA) 
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equipped with an UV/visible detector, binary solvent manager and 
autosampler system. The output signal was checked and processed 
using Empower 2 software. The pH of the solutions was measured 
by a pH meter (Mettler-Toledo, Switzerland).  
Chemicals and reagents 
Spectrum Pharma Research Solutions (Hyderabad) supplied a 
sample of Cefdinir. Orthophosphoric acid and perchloric acids were 
purchased from RFCL, Rankeem Limited. HPLC grade water and 
acetonitrile were obtained from Rankem, Avantor Performance 
Material India Limited. High purity water was obtained by using 
Millipore Milli Q Plus water purification system. 
Chromatographic conditions 
The method was developed by using an Acquity SB C18 (100 × 2 
mm) 1.8μm column with an isocratic mobile phase containing a 
mixture of orthophosphoric acid and acetonitrile (60:40 v/v). The 
pH was adjusted to 2.8. The mobile phase was filtered through the 
0.22µ filter under vacuum filtration. Flow rate of the mobile phase 
was 0.3 ml/min. The column temperature was maintained at 30 °C 
and the eluted compounds were monitored at the wavelength of 285 
nm. The sample injection volume was 1μl.  
Preparation of solutions 
Preparation of diluents 
The diluent used for the analysis was prepared by using 
homogenous mixture of 500 ml of water and 500 ml acetonitrile.  
Preparation of mobile phase 
A mixture of orthophosphoric acid and acetonitrile in the ratio of 
60:40 (v/v) was prepared and the pH was adjusted to 2.8 with 
ortho-phosphoric acid. The mixture was filtered through 0.22μ 
membrane filter under vacuum filtration. 
Preparation of standard solution 
A 25 mg of cefdinir was weighed on a calibrated analytical balance 
and transferred accurately into a 25 ml clean and dry volumetric 
flask. It was further diluted to volume with 1:1 acetonitrile and 
water (25 ml) to produce 25μg/ml stock solution. This stock 
solution was diluted appropriately to prepare standard of the 
100μg/ml.  
Preparation of sample solution 
The sample solution was prepared by taking 10 tablets of cefdinir 
which were weighed individually; their mean weight was 
determined and was ground to a fine powder using a glass mortar 
and pestle. An equivalent of 25 mg of cefdinir was accurately 
weighed and transferred to a separate 25 ml volumetric flask. The 
volume was adjusted with acetonitrile and water (1:1 v/v) and the 
resultant solution was sonicated for 15 min, filtered through a 0.22μ 
membrane filter under vacuum filtration.  
Validation procedure 
Method validation was achieved as per ICH guidelines for 
determination of the cefdinir [5]. The following validation features 
were addressed: linearity, detection limit, quantification limit, 
precision, accuracy, robustness and specificity.  
Linearity 
Standard solutions at six different concentration levels ranging from 
25µg/ml to 150µg/ml were prepared and analyzed in order to 
demonstrate the linearity. The regression curve was obtained by 
plotting peak area versus concentration. The regression equation 
was obtained by using the least squares method [15]. 
Limits of detection and quantification (LOD and LOQ)  
The sensitivity of the method was measured by calculating the limit 
of detection and limit of quantification. The LOD and LOQ were 
assessed at signals to noise ratio of 3:1 and 10:1 respectively by 
injecting a series of dilute solutions with known concentrations.  
Precision  
The Precision of the method was determined by injecting a standard 
solution of cefdinir for six times and measured the area for all six 
injections in UPLC chromatographic system.  
Accuracy  
The standard addition and recovery experiments were conducted to 
demonstrate the accuracy of the method. The accuracy of the 
method evaluated in triplicate at three concentration levels, i.e. 50%, 
100% and 150% of target test concentration and the percentages of 
recoveries were calculated.  
Robustness 
The robustness of a method was demonstrated by altering 
experimental conditions and chromatographic resolution to evaluate 
robustness. The deliberate changes were made in the chromate-
graphic conditions, viz. change in flow rate by±0.1 ml/min and 
change in the column temperature±5 °C. 
Specificity  
Forced degradation studies of cefdinir was carried out under 
conditions of acid hydrolysis (5N hydrochloric acid was added and 
refluxed for 30 min at 60 °), base hydrolysis (5N sodium hydroxide 
was added and refluxed for 30 min at 60 °), peroxide treatment 
(20% hydrogen peroxide was kept for 30 min at 60 °), thermal 
degradation (solid API was heated at 105 ° for 6 h in an oven) and 
photolytic degradation (sample was exposed to UV for one day). The 
treated samples were diluted with diluent to the desired 
concentration of 100µg/ml and injected in the established method. 
All the stressed samples are quantified for cefdinir [16].  
RESULTS 
Chromatograms depicting the method development of cefdinir  
The chromatogram (fig. 1) obtained for method 1 was found to be 
more tailing factor. So, another set of trials were performed for 
reducing the tailing factor. The chromatogram (fig. 2) attained for 
method 2 was found to be a good peak shape but it was shown more 
retention time. Accordingly, further trials were performed by 
altering the mobile phase composition. The chromatogram (fig. 3) 
accessed for method 3 was found to be more retention time and it 
was not properly separated. Similarly, the chromatogram (fig. 4) 
gathered for method 4 was established to be consisting with an extra 
peak. Finally, the chromatogram (fig. 5) for method 5 was found to 
be a perfectly eluted peak with excellent peak shape. The tailing 
factor and retention time were observed within the limits. Therefore 
the mobile phase ratio was fixed at 60:40 (buffer: solvent).  
 
Fig. 1: UPLC chromatogram for method 1. 
 
System suitability criteria  
A system suitability test was well defined based on the results found 
in several representative chromatograms. The column efficiency was 
determined from the analyte peak, the tailing factor was<2.0 and 
RSD for six replicate injection of system suitability solution 
were<5.0%. All the system suitability criteria’s during validation of 
the study and batch analysis study were within the acceptance limit. 
The results of system suitability are depicted in table 1. 
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Fig. 2: UPLC chromatogram for method 2 
 
 
Fig. 3: UPLC chromatogram for method 3 
 
 
Fig. 4: UPLC chromatogram for method 4 
 
 
Fig. 5: UPLC chromatogram for method 5 
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Table 1: System suitability data of cefdinir 
Peak name Cefdinir 
RT 0.681 
Area(mean) 1040275 
USP plate count 4085 
USP tailing 1.5 
Standard Deviation 13158.9 
%RSD 1.3 
 
Analytical method validation 
Linearity  
The UPLC chromatogram data for determination of linearity was 
mentioned in table 2. The linearity of the optimized method was 
determined for six concentrations and the correlation coefficient 
was found to be 0.9993 for cefdinir. It showed that the developed 
method followed Beer-Lambert’s law within the range of 25–
150μg/ml. 
LOD and LOQ  
The limits of detection and quantification values were found to be 
0.17 and 0.51µg/ml. Chromatograms of LOD and LOQ were shown in 
fig 6 and7, respectively. 
  
Table 2: linearity data of cefdinir 
Linearity level (%) Concentration (ppm) Area 
0 0 0 
25 25 269751 
50 50 538538 
75 75 782019 
100 100 1030526 
125 125 1314152 
150 150 1541214 
 
 
Fig. 6: LOD chromatogram of cefdinir 
 
 
Fig. 7: LOQ chromatogram of Cefdinir 
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The UPLC chromatogram data for inter-day precision and intraday 
precision were shown in table 3 and table 4, respectively. The data 
for inter-day precision revealed that the % RSD from six replicate 
injections of the sample solution was 0.8% which was within the 
limits specified (% RSD NMT 2.0%). Chromatogram data for 
intraday precision revealed that % RSD for six replicate injections of 
the sample solution was found to be 0.9% which was within the 
limits specified (% RSD NMT 2.0%). 
  
Table 3: Interday precision data of cefdinir 








Standard Deviation 8101.3 
% RSD 0.8 
 
Table 4: Intraday precision data of cefdinir 








Standard Deviation 9676.9 
% RSD 0.9 
 
Accuracy  
The accuracy of the method was evaluated in triplicate at the 
concentration levels like 50, 100, and 150% of the target test 
concentration. The percentage of the recovery was calculated and 
obtained ranged from 98% to 102%. Data was represented in table 5.  
Robustness 
The UPLC chromatogram data for determining the robustness of 
the method was shown in table 6. The data revealed that % RSD 
for decrease and increase in flow rate for cefdinir were 1.2 and 0.8, 
respectively which were within the limits specified (% RSD NMT 
2.0%). The % RSD for mobile phase ratios of the drug was 1.0 and 
1.3, respectively which were within the limits specified (% RSD 
NMT 2.0%). The percentage RSD for decrease and increase in 
column oven temperature were 0.9 and 0.3, respectively which 
were within the limits specified (% RSD NMT 2.0%). From the 
above study, it can be proven that the flow rate, mobile phase ratio 
and column oven temperature were robust in the allowable 
variations. 
Specificity  
The forced degradation study by using UPLC revealed that the drug 
was degraded under the influence of acid, alkali and hydrogen 
peroxide solution, thermal and photolytic conditions. Data was 
recorded in table 7. 
 
Table 5: Accuracy data of cefdinir 
% level Amount spiked (μg/ml) % recovery Mean % recovery 
50% 50 99.73 99.22% 
50 98.91 
50 98.17 
100% 100 100.01 
100 99.59 
100 98.64 




Table 6: Robustness data of cefdinir 
S. No. Parameter % RSD 
1 Flow Minus 1.2 
2 Flow Plus 0.8 
3 Mobile phase Minus 1.0 
4 Mobile phase Plus 1.3 
5 Temperature minus 0.9 
6 Temperature plus 0.3 
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Table 7: Degradation data of cefdinir 
S. No. Degradation condition % drug degraded 
1 Acid 3.95 
2 Alkali 2.46 
3 Oxidation 1.58 
4 Thermal 1.11 
5 UV 1.05 
6 Water 0.64 
 
DISCUSSION 
Validation of the developed method was done as per ICH guidelines. 
The method was found to be specific, stability indicating. This 
method exhibited an excellent performance in terms of sensitivity 
and speed. Satisfactory results were obtained from validation of the 
method. The correlation coefficient was found to be greater than 
0.98 which was within the limits specified (NLT 0.99). Hence, the 
results shown that an excellent correlation existed between the peak 
area and concentration of the analyte. The high value of the 
correlation coefficient showed good linearity. The standard addition 
and recovery experiments were conducted to demonstrate the 
accuracy of the method. The recovery was found to be in the range 
of 98-102%. High recovery results obtained from the proposed 
UPLC assay method indicates that this method can be used for 
quantitative routine quality control analysis of pharmaceutical 
dosage forms. The precision of a method determines the closeness of 
agreement between a series of measurements of the same sample. 
The %RSD values were found to be 0.8 and 0.9µg/ml. These values 
were well within the generally acceptable limit of <2%. Hence, 
confirming the good precision of the assay method. The limit of 
detection (LOD) of a compound is defined as the lowest 
concentration that can be detected. The limit of quantification (LOQ) 
is the lowest concentration of a compound that can be quantified. 
The sensitivity of the method was measured by calculating the limit 
of detection and limit of quantification [17]. It was observed that the 
LOD was 0.15µg/ml and LOQ was 0.51μg/ml. It was particularly 
important to note that the injection volume used in this method was 
only 1.0μl. Therefore, the minimum amount of analyte that can be 
quantified in a single injection was low. This proves the sensitivity of 
the method and its effectiveness. The ability of this method to 
separate and accurately measure the peak of interest indicates the 
specificity of the method [18]. The robustness of an analytical 
procedure is the measure of its ability to remain unaffected by small, 
but deliberate, variations in method parameters and provides sign of 
its reliability during normal usage. In all the deliberate varied 
chromatographic conditions the tailing factor of cefdinir was less 
than 2.0. There was a very slight variation in the resolution and 
tailing factor results observed in all the robustness conditions 
illustrating the robustness of the method. The peak purity test 
results derived from UV detector confirmed that the cefdinir peaks 
were pure and homogeneous in all the analyzed stressed conditions. 
This shows that the method is specific and stability indicating. Purity 
angle for the selected drug components in all stress conditions was 
found to be less than the threshold angle.  
CONCLUSION 
A new sensitive, simple, rapid, suitable, precise, accurate and 
stability indicating RP-UPLC method coupled with UV detector has 
been developed. The developed method was completely validated 
with respect to specificity, system suitability, linearity, limit of 
detection and quantification, accuracy, precision and robustness. 
The result of validation showed satisfactory data for all the 
parameters tested. 
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